• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Zydus Cadila launches anti-hypertension drugs in USA

      Posted AtSify.com

      Ahmedabad-based drug major Zydus Cadila today said that it has received approval from the US Food and Drug Administration (USFDA) to market two anti-hypertension drugs in the US market. These include Losartan Potassium tablets and Losartan Potassium plus Hydrochorothiazide tablets.

      The company has approval to market Losartan Potassium tablets in the denominations of 25 mg, 50mg, and 100mg, while it can sell the Lostartan plus Hydrochorothiazide tablets in denominations of 50/12.5mg and 100/25 mg. Zydus has already launched both the products in the US market post approval from the health regulator.

      As par NDC Health, sales of Losartan Potassium tablets in the US market is estimated at $1.3 billion and that of Losartan Potassium plus Hydrochlorothiazide tablets is estimated at $944 million in 2010.

      The Ahmedabad-based pharma major had launched Tamsulosin capsules (0.4mg) in the US in April.

      Following this approval, the group has now approvals for 56 products for the US market and has so far filed 113 abbreviated new drug application (ANDA) since the commencement of filing process in the fiscal 2003-04 fiscal.

      Zydus launched the anti-hypertensive drugs in the US market on the same day that it received the approval. It had done the same in case of Tasulosin capsules earlier this year. Apart from these two, the Group has had three more first day launches in the US market in 2008-09.

      Oct 12, 2010


      Share this Article!

    Back to top^